Hyderabad, Feb 3 Ocugen Inc and Bharat Biotech on Tuesday announced they have entered into a definitive agreement to co-develop, supply and commercialise Bharat Biotech’s Covaxin, an advanced stage whole-virion inactivated Covid-19 vaccine candidate, for the United States market. Ocugen,
New Delhi, Jan 16 The Union Health Ministry on Saturday asked the Ministry of External Affairs (MEA) to consider contacting Bharat Biotech for the procurement of 8.1 lakh doses of Covaxin to be given to different countries as a goodwill
Hyderabad, Jan 12 Bharat Biotech on Tuesday announced it has signed an agreement with Precisa Medicamentos for the supplies of its Covid vaccine ‘Covaxin’ to Brazil. A team from Precisa Medicamentos visited the Bharat Biotech facility here last week to
New Delhi, Jan 5 In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, on Tuesday communicated their combined intent to develop manufacture and supply the Covid-19
New Delhi, Jan 4 Hyderabad-based Bharat Biotech said on Monday that its vaccine is efficient against the mutant strain of novel coronavirus found in the UK while announcing that its data would be made public within a week. CMD Dr
New Delhi, Jan 4 Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccine, Covaxin, to the government for further distribution in the immunisation drive the country is set to start in coming days, its CMD Dr Krishna
Hyderabad, Jan 3 Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat Biotech claimed on Sunday that its vaccine generated excellent safety data with robust
New Delhi, Jan 2 A committee of experts assessing the coronavirus vaccines has called Hyderabad-based Bharat Biotech for a meeting at 1.30 pm on Saturday, a day after the firm was asked to present more data on its ‘Covaxin’ to
Hyderabad, Dec 30 Bharat Biotech said on Tuesday that its vaccine candidate, Covaxin, will be effective in dealing with new strains of coronavirus. Bharat Biotech Chairman and Managing Director Krishna Ella said the protein components of inactive Covaxin will take
Hyderabad, Dec 22 Bharat Biotech on Tuesday announced successful recruitment of 13,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for Phase III clinical trial of its coronavirus vaccine Covaxin across multiple sites in India. The Phase
New Delhi, Dec 21 Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine, DNA-based vaccine, vector-based vaccine, or live attenuated vaccines, etc., the inactivated vaccines being developed by it for Covid 19 are safest,
Hyderabad, Dec 9 (IANS) Envoys of 64 countries on Wednesday visited the facilities of Bharat Biotech and Biological E, which are developing vaccines for coronavirus. After landing in Hyderabad by a special Air India flight, the Ambassadors and High Commissioners from
Hyderabad, Nov 16 Even as India’s first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday raised the logistical query on “how to vaccinate 1.3 billion (130 crore) people with two injectable doses. Terming
New Delhi, Oct 19 Union Health Minister Harsh Vardhan on Sunday informed that Bharat Biotech will develop an intranasal vaccine for Sars-CoV-2, the virus that causes Covid-19. The minister said that the Hyderabad-based drugs and vaccine research and manufacturing company
Hyderabad, July 18 Hyderabad-based Bharat Biotech on Friday announced that the Phase-I clinical trials of India’s first indigenous Covid-19 vaccine Covaxin began across the country on July 15. “This is a randomised, double-blind, placebo-controlled clinical trial on 375 volunteers in
 |
 |
 |
|---|---|---|
 |
 |
 |
 |
 |
 |
 |
 |
 |
